UBS lowered the firm’s price target on Helen of Troy (HELE) to $25 from $27 and keeps a Neutral rating on the shares. Helen of Troy reported a Q2 beat, as stronger-than-expected sales growth more than offset weaker gross and operating margin performance, though guidance for Q3 and FY26 fell short of Street expectations at the bottom line, the analyst tells investors in a research note. Investors will likely remain on the sidelines until there is greater clarity around execution, margin stabilization, and the path toward sustainable growth, UBS adds.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HELE:
